General Information
Revision date
2026-05-14
Product name
according to its REACH registration
Product name
according to its REACH registration
Identification on the label/Trade name
Waxtreat 3553ND
CAS No.
1189173-42-9
REACH No
01-2119463583-34-XXXX
1.2.1 Relevant identified uses
Industry sector Oilfield
Emergency telephone
+47 55 36 34 50, +47 22 59 13 00
Icons in SDS
Company Information
company name
Clariant Oil Services Scandinavia AS
e-mail address of the competent person responsible for the Safety Data Sheet
SDS.Europe@clariant.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H336, H411
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H304 May be fatal if swallowed and enters airways. H336 May cause drowsiness or dizziness. H411 Toxic to aquatic life with long lasting effects. cracking.
Supplemental label elements
EUH066 Repeated exposure may cause skin dryness or
Prevention
P261 Avoid breathing mist or vapours. P273 Avoid release to the environment.
Response
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P331 Do NOT induce vomiting. P391 Collect spillage.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. No additional hazards are known except those derived from the labelling.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Specific target organ toxicity - single H336: May cause drowsiness or dizziness. exposure, Category 3, Central nervous system Aspiration hazard, Category 1 H304: May be fatal if swallowed and enters airways. Long-term (chronic) aquatic hazard, H411: Toxic to aquatic life with long lasting effects.
